Transarterial Chemoembolization Combined with Tyrosine Kinase Inhibitors Plus Immune Checkpoint Inhibitors for Advanced Hepatocellular Carcinoma: A Propensity Score Matching AnalysisBenjian Gao, Bo Li, Jie Liu et al.|Journal of Hepatocellular Carcinoma|2023Cited by 10
The efficacy of transarterial chemoembolization in downstaging unresectable hepatocellular carcinoma to curative therapy: a predicted regression modelHaomin Lin, Song Su, Bin Luo et al.|Investigational New Drugs|2022Cited by 6